Stay updated on Ipilimumab+Nivolumab for Stage IV IBC Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab+Nivolumab for Stage IV IBC Clinical Trial page.

Latest updates to the Ipilimumab+Nivolumab for Stage IV IBC Clinical Trial page
- Check3 days agoChange DetectedA new page revision identifier v3.6.2 has been added to the page. The previous v3.6.0 revision has been removed.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedThe recruitment status was updated to indicate no participants are being sought, signaling that enrollment has ended. Additional sections and navigational elements—How to Read a Study Record, Common Questions, How to Join a Study, and the Intervention/Treatment heading—were added, and the page revision shows v3.6.0.SummaryDifference0.5%

- Check25 days agoChange DetectedRevision: v3.5.5 has replaced v3.5.4, signaling a new deployment of page updates.SummaryDifference0.0%

- Check46 days agoChange DetectedThe page now shows a newer revision tag, v3.5.4. The previous tag, v3.5.3, has been removed, signaling a minor metadata update to the page.SummaryDifference0.0%

- Check61 days agoChange DetectedRevision metadata updated from v3.5.2 to v3.5.3, indicating a new version of the page. This is a maintenance/version update that does not alter the study details or content.SummaryDifference0.0%

- Check75 days agoChange DetectedAdded a new revision note 'Revision: v3.5.2' and removed the previous revision note 'Revision: v3.5.0'.SummaryDifference0.0%

Stay in the know with updates to Ipilimumab+Nivolumab for Stage IV IBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab+Nivolumab for Stage IV IBC Clinical Trial page.